4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate | CAS:1276666-12-6

We serve 4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate CAS:1276666-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate

Chemical Name:  4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate
CAS.NO:  1276666-12-6
Synonyms:
2-Butanone, 4-[(2-aminoethyl)(5-chloro-2-benzoxazolyl)amino]-, methanesulfonate (1:2)
4-[(2-Aminoethyl)(5-chloro-1,3-benzoxazol-2-yl)amino]-2-butanone methanesulfonate (1:2)

Molecular Formula: C15H24ClN3O8S2
Molecular Weight:   473.94900

Physical and Chemical Properties:
Density: /
Boiling point: /
Melting point: /
Flash point: /
Refractive index: /

Specification:
Appearance: white powder
Purity:≥99.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
 Intermediates of Suvorexant CAS:1030377-33-3.



Contact us for information like 4-[(2-Aminoethyl)(5-chloro-2-benzoxazolyl)amino]-2-butanone methanesulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(2-Aminoethyl)(5-chloro-1,3-benzoxazol-2-yl)amino]-2-butanone methanesulfonate (1:2) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Butanone, 4-[(2-aminoethyl)(5-chloro-2-benzoxazolyl)amino]-, methanesulfonate (1:2) Use and application,4-[(2-Aminoethyl)(5-chloro-1,3-benzoxazol-2-yl)amino]-2-butanone methanesulfonate (1:2) technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.Trimethoxyoctylsilane manufacturer Delta moved the date up after the US State Department warned that people should not travel to China due to concerns about the spread of coronavirus, which was first discovered in Wuhan, Hubei province, in December.2-Amino-6-chloro-4-nitrophenol supplier DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.